Programmed death ligand 1 (PD-L1) in colon cancer and its interaction with budding and tumor-infiltrating lymphocytes (TILs) as tumor-host antagonists

por Lang-Schwarz, Corinna, Melcher, Balint, Hartmann, Arndt, Bertz, Simone, Dregelies, Theresa, Lang-Schwarz, Klaus, Vieth, Michael, Sterlacci, William
Publicado 2021

Adjuvant chemotherapy in stage II and III colon cancer: the role of the “budding and TILs-(tumor-infiltrating lymphocytes) combination” as tumor-host antagonists

por Lang-Schwarz, Corinna, Melcher, Balint, Dregelies, Theresa, Norouzzadeh, Zahra, Rund-Küffner, Stefanie, Lang-Schwarz, Klaus, Vieth, Michael, Sterlacci, William
Publicado 2021

Inflammation-Induced Mucosal KYNU Expression Identifies Human Ileal Crohn’s Disease

por Huhn, Meik, Herrero San Juan, Martina, Melcher, Balint, Dreis, Caroline, Schmidt, Katrin G., Schwiebs, Anja, Collins, Janet, Pfeilschifter, Josef M., Vieth, Michael, Stein, Jürgen, Radeke, Heinfried H.
Publicado 2020

The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness

por Grinat, Johanna, Heuberger, Julian, Vidal, Ramon Oliveira, Goveas, Neha, Kosel, Frauke, Berenguer-Llergo, Antoni, Kranz, Andrea, Wulf-Goldenberg, Annika, Behrens, Diana, Melcher, Bálint, Sauer, Sascha, Vieth, Michael, Batlle, Eduard, Stewart, A. Francis, Birchmeier, Walter
Publicado 2020